During cardiopulmonary bypass (CPB), which is frequently utilized in open-heart surgery, the maintenance of circulation in a non-physiological environment may lead to alterations in the properties of circulating blood components. In our study, we aimed to evaluate these changes using contemporary methodologies.
Methods
The study included 48 patients who underwent cardiac surgery with CPB. CPB duration and hypothermia degree were recorded and analyzed. Erythrocyte deformability (ED), erythrocyte aggregation (EA), whole blood viscosity (WBV), total oxidant status (TOS), and total antioxidant status (TAS) were measured; ED and EA were measured using LORRCA (RR Mechatronics, Hoorn, Netherlands).
Results
Compared to the preoperative period, a decrease in postoperative ED, EA, and WBV was observed. No significant change was detected in TAS levels; however, TOS levels were found to be elevated. No statistically significant correlation was observed between perioperative patient temperature, CPB duration, and ED, EA, or WBV values.
Conclusions
In patients undergoing surgery with CPB, a postoperative decrease in ED, EA, and WBV was demonstrated. Previous studies have suggested that the decline in ED is associated with blood transfusion. However, the significant reduction in ED observed in our study, even in patients who did not receive blood transfusions, is noteworthy.
HaslamPLTownsendPJBranthwaiteMA. Complement activation during cardiopulmonary bypass. Anaesthesia1980; 35: 22–26.
2.
MammenEFKoetsMHWashingtonBC, et al.Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost1985; 11: 281–292.
3.
DormandyJA. Red cell deformability. Eur Neurol1983; 22: 23–29.
4.
MokkenFCKedariaMHennyCP, et al.The clinical importance of erythrocyte deformability, a hemorrheological parameter. Ann Hematol1992; 64: 113–122.
5.
BessisMMohandasNFeoC. Automated ektacytometry: a new method of measuring red cell deformability and red cell indices. Blood Cells1980; 6: 315–327.
6.
HochmuthRM. Micropipette aspiration of living cells. J Biomech2000; 33: 15–22.
7.
HirayamaTYamaguchiHAllersM, et al.Changes in red cell deformability associated with anaesthesia and cardiopulmonary bypass in open-heart surgery. Scand Cardiovasc J1985; 19: 257–262.
8.
IchikawaJKoshinoIArashikiN, et al.Changes in erythrocyte morphology at initiation of cardiopulmonary bypass without blood transfusion were not associated with less deformability during cardiac surgery. J Cardiothorac Vasc Anesth2019; 33: 2960–2967.
9.
KestevenPJL. Haemostatic changes during cardiopulmonary bypass. Perfusion1990; 5: 9–19.
10.
FerranteMSPisanoCVan RothemJ, et al.Cerebrovascular events after cardiovascular surgery: diagnosis, management and prevention strategies. Kardiochir TorakoChirurgia Pol2023; 20: 18.
11.
BiltoYY. Loss of erythrocyte deformability under oxidative stress is caused by protein oxidation with consequent degradation rather than by lipid peroxidation. J Adv Med Medical Res2015; 8: 9–21.
12.
KimDHKimYKWonDIl, et al.Assessment of hemorheological deformability of human red cells exposed to tert-butyl hydroperoxide, verapamil and ascorbate by ektacytometer. Korean J Labor Med2008; 28: 325–331.
13.
BaskurtOKBoynardMCokeletGC, et al.New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc2009; 42: 75–97.
14.
BaskurtOKMeiselmanHJ. Blood rheology and hemodynamics. Semin Thromb Hemost2003; 29: 435–450.
15.
ErelO. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem2004; 37: 277–285.
16.
ErelO. A new automated colorimetric method for measuring total oxidant status. Clin Biochem2005; 38: 1103–1111.
17.
GordonRJRavinMDaicoffGR,et al.Effects of hemodilution on hypotention during cardiopulmonary bypass. Anesth Analg1975; 54: 482–488.
18.
SalariaONBarodkaVMHogueCW, et al.Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg2014; 118: 1179–1187.
19.
EkeströmSKoulBLSonnenfeldT. Decreased red cell deformability following open-heart surgery. Scand Cardiovasc J1983; 17: 41–44.
20.
PappJTothASandorB, et al.The influence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters. Clin Hemorheol Microcirc2011; 49: 331–346.
21.
GraaffRGuYJBoonstraPW, et al.Analysis of red blood cell aggregation in cardio-pulmonary bypass (CPB) surgery. Int J Artif Organs2004; 27: 488–494.
22.
MorariuAMGuYJHuetRCGG, et al.Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?Europ J Cardio-Thoracic Surg: OfficJ Eur Assoc Cardio-Thora Surg2004; 26: 939–946.
23.
GuYJGraaffRde HoogE, et al.Influence of hemodilution of plasma proteins on erythrocyte aggregability: an in vivo study in patients undergoing cardiopulmonary bypass. Clin Hemorheol Microcirc2005; 33: 95–107.
24.
ChienSUsamiSDellenbackRJ, et al.Blood viscosity: influence of erythrocyte aggregation. Science1967; 157: 829–831.
MenteseUDoganOVTuranI, et al.Oxidant-antioxidant balance during on-pump coronary artery bypass grafting. Scientific World J2014; 2014. https://doi.org/10.1155/2014/263058
27.
HuisjesRBogdanovaAvan SolingeWW, et al.Squeezing for life - properties of red blood cell deformability. Front Physiol2018; 9: 350140.
28.
KleiTVan BruggenRDalimotJ, et al.Hemolysis in the spleen drives erythrocyte turnover. Blood2019; 134: 946–946.
29.
BosmanGJCGMWerreJMWillekensFLA,et al.Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med2008; 18: 335–347.
30.
BosmanGJCGMStappersMNovotnýMJ. Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion. Blood Transfus2010; 8: 48–52.
31.
STRUMIAMMDUGANACOLWELLLS. The measure of erythropoiesis in anemias. II. The immediate and subsequent loss of transfused erythrocytes in healthy subjects. Blood1962; 19: 115–122.
BakerIAPickeringJElwoodPC, et al.Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the caerphilly and speedwell cohort. Thromb Haemostasis2002; 87: 421–425.
34.
KoenigWErnstEMatraiA. Blood rheology associated with cardiovascular risk factors and chronic cardiovascular diseases: results of an epidemiologic cross-sectional study. Angiology1988; 39: 986–995.
35.
KoenigWSundMLöwelH, et al.Association between plasma viscosity and all-cause mortality: results from the MONICA-augsburg cohort study 1984-92. Br J Haematol2000; 109: 453–458.
36.
YarnellJWBakerIASweetnamPM, et al.Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease - the caerphilly and speedwell collaborative heart disease studies. Circulation1991; 83: 836–844.
37.
FÅHRAEUSR. The influence of the rouleau formation of the erythrocytes on the rheology of the blood. Acta Med Scand1958; 161: 151–165.
38.
WeiselJWLitvinovRI. Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost: JTH2019; 17: 271–282.
39.
AkmanTAkarsuMAkpinarH, et al.Erythrocyte deformability and oxidative stress in inflammatory bowel disease. Dig Dis Sci2012; 57: 458–464.
40.
BiltoYYKumarS. Loss of erythrocyte deformability under oxidative stress is caused by protein oxidation with consequent degradation rather than by lipid peroxidation. J Adv Med Medical Res2015; 8: 9–21.
41.
DiederichLSuvoravaTSansoneR, et al.On the effects of reactive oxygen species and nitric oxide on red blood cell deformability. Front Physiol2018; 9: 324898.
42.
TaiYHWuHLChuYH, et al.Vitamin C supplementation attenuates oxidative stress and improves erythrocyte deformability in cardiac surgery with cardiopulmonary bypass. Chin J Physiol2022; 65: 241–249.
